Indeed, to our knowledge, only two previous studies have compared CD8+ T‐cell responses to different TAA in HCC patients.12 Moreover, these studies were limited to analyses of previously described epitopes restricted by human leukocyte antigen (HLA)‐A*02 and HLA‐A*24, respectively. The gene discussed is CD8A; the disease is hepatocellular carcinoma.